{"company":{"id":3783063,"name":"Neurogastrx","domain":"neurogastrx.com","url":"https://alion.io/company/world-3783063"},"section":"news","answer":"Neurogastrx: 5 headlines on record, 0 headlines in the last 90 days. Its story counts 3 milestones.","figures":[{"label":"Headlines","value":"5"},{"label":"In 90 days","value":"0"},{"label":"Milestones","value":"3"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":3},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":3}],"news":[{"date":"2025-11-07","kind":"News","title":"PRN_FinancialWrapper","source":"PRNewswire","url":"https://markets.financialcontent.com/prnews.investoruprising/article/gnwcq-2025-11-7-neurogastrx-announces-ng101-phase-2-clinical-study-demonstrating-significant-reductions-in-nausea-and-vomiting-induced-by-glp-1-receptor-agonist-semaglutide"},{"date":"2025-10-07","kind":"News","title":"Neurogastrx to Present Proof-of-Concept Clinical Data on Oral Candidate NG101 to Reduce Nausea & Vomiting Associated with GLP-1 Agonists at ObesityWeek","source":"markets.businessinsider.com","url":"https://markets.businessinsider.com/news/stocks/neurogastrx-to-present-proof-of-concept-clinical-data-on-oral-candidate-ng101-to-reduce-nausea-vomiting-associated-with-glp-1-agonists-at-obesityweek-1035272073"},{"date":"2024-10-16","kind":"Press release","title":"Neurogastrx Announces Positive Proof-of-Concept Data for Investigational Drug NG101 in Reducing Nausea and Vomiting Associated with the Administration of GLP-1 Agonist Medication","source":"The Manila Times","url":"https://manilatimes.net/2024/10/16/tmt-newswire/globenewswire/neurogastrx-announces-positive-proof-of-concept-data-for-investigational-drug-ng101-in-reducing-nausea-and-vomiting-associated-with-the-administration-of-glp-1-agonist-medication/1985461"}],"story":[{"title":"Raised a round Venture round $60M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1870700/000187070021000002/"},{"title":"Raised a round Venture round $20M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1870700/000187070021000001/"},{"title":"Founded"}],"as_of":"2026-11-17","cite":"Neurogastrx, News. Alion, Nov 17, 2026. https://alion.io/company/world-3783063/news","html_url":"https://alion.io/company/world-3783063/news","json_url":"https://alion.io/company/world-3783063/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T21:59:53Z"}}